Clinical Trials Browser

Terminated × INDUSTRY × Ondansetron × Clear all

NCT02592707 2023-07-19

Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETs

Phase 1/2 Terminated

40 enrolled 37 charts

Neuroendocrine Tumors

NCT00285051 2020-12-23

Comparison of Delta-8-THC to Ondansetron in the Prevention of Acute Nausea From Moderately Emetogenic Chemotherapy

Phase 2 Terminated

Nausea, Neoplasms, Vomiting